06.10.2017 15:47:11

Redhill Biopharma Buy

Der Analyst Seaport Global Securities hat die Einstufung für Redhill Biopharma Ltd (spons. ADRs) auf "Buy" mit einem Kursziel von 19 USD belassen.
Zusammenfassung: Redhill Biopharma Ltd (spons. ADRs) Buy
Unternehmen:
Redhill Biopharma Ltd (spons. ADRs)
Analyst:
Seaport Global Securities
Kursziel:
$ 19,00
Rating jetzt:
Buy
Kurs*:
8,23 €
Abst. Kursziel*:
130,97%
Rating update:
initiated
Kurs aktuell:
$ 4,56
Abst. Kursziel aktuell:
316,67%
Analyst Name::
-
KGV*:
-
* Zum Zeitpunkt der Analyse

Aktienempfehlungen zu Redhill Biopharma Ltd (spons. ADRs)

  • Alle
  • Buy
  • Hold
  • Sell
06.10.17 Redhill Biopharma Buy Seaport Global Securities
04.10.17 Redhill Biopharma Buy H.C. Wainwright & Co.
mehr Aktienempfehlungen

Aktien in diesem Artikel

Redhill Biopharma Ltd (spons. ADRs) 3,85 0,00% Redhill Biopharma Ltd (spons. ADRs)

Aktienempfehlungen

12.12.17 Urban Outfitters Outperform Wolfe Research
12.12.17 Nokia overweight JP Morgan Chase & Co.
12.12.17 STMicroelectronics overweight JP Morgan Chase & Co.
12.12.17 Whiting Petroleum Hold R. F. Lafferty
12.12.17 JetBlue Airways Market Perform Cowen and Company, LLC
12.12.17 US Bancorp Neutral UBS AG
12.12.17 SunTrust Banks Buy UBS AG
12.12.17 Regions Financial Neutral UBS AG
12.12.17 Spark Therapeutics Neutral UBS AG
12.12.17 M&T Bank Neutral UBS AG
12.12.17 ConAgra Foods Neutral UBS AG
12.12.17 JCDecaux Hold Commerzbank AG
12.12.17 Dialog Semiconductor Neutral JP Morgan Chase & Co.
12.12.17 Unibail-Rodamco overweight JP Morgan Chase & Co.
12.12.17 Bill Barrett Equal weight Barclays Capital
12.12.17 Stitch Fi a Equal weight Barclays Capital
12.12.17 Michaels Companies Hold Deutsche Bank AG
12.12.17 Zurich Insurance Conviction Buy Goldman Sachs Group Inc.
12.12.17 SailPoint Technologies Hold Canaccord Adams
12.12.17 Spark Therapeutics Buy Chardan Capital Markets
12.12.17 DR Horton Neutral Wedbush Morgan Securities Inc.
12.12.17 Fraport Hold Commerzbank AG
12.12.17 ExxonMobil Neutral JP Morgan Chase & Co.
12.12.17 HelloFresh Outperform BNP PARIBAS
12.12.17 Eni Neutral Credit Suisse Group
12.12.17 TOTAL Neutral Credit Suisse Group
12.12.17 Zurich Insurance Neutral JP Morgan Chase & Co.
12.12.17 Aroundtown SA buy Deutsche Bank AG
12.12.17 ADO Properties buy Deutsche Bank AG
12.12.17 Deutsche Wohnen buy Deutsche Bank AG
12.12.17 LANXESS Hold Deutsche Bank AG
12.12.17 Ryanair buy Deutsche Bank AG
12.12.17 Fraport Hold Commerzbank AG
12.12.17 Roche Hold Deutsche Bank AG
12.12.17 Novo Nordisk buy UBS AG
12.12.17 Vodafone Group Conviction Buy List Goldman Sachs Group Inc.
12.12.17 QIAGEN buy Commerzbank AG
12.12.17 McDonalds buy Goldman Sachs Group Inc.
12.12.17 Gamesa Neutral Goldman Sachs Group Inc.
12.12.17 UniCredit Neutral UBS AG
12.12.17 UniCredit overweight JP Morgan Chase & Co.
12.12.17 Boeing overweight JP Morgan Chase & Co.
12.12.17 UniCredit Conviction Buy List Goldman Sachs Group Inc.
12.12.17 UniCredit Equal-Weight Morgan Stanley
12.12.17 Oracle overweight JP Morgan Chase & Co.
12.12.17 Intel Neutral Goldman Sachs Group Inc.
12.12.17 Sysco Buy Pivotal Research Group
12.12.17 Semtech Buy Needham & Company, LLC
12.12.17 Mattel Neutral Monness, Crespi, Hardt & Co.
12.12.17 Proteostasis Therapeutics Outperform Robert W. Baird & Co. Incorporated